Tribun Health (EPA:GIB.A) | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55332	Articles
62460	Communiqués

Accueil
Sociétés
Tribun Health

BRÈVE

publiée le 28/08/2024 à 09:05, il y a 2 mois 24 jours

Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions

Healthcare Technology Digital Pathology Cancer Detection AI Diagnostics Clinical Workflows
BRÈVE

publiée le 28/08/2024 à 09:05, il y a 2 mois 24 jours

Tribun Health s'associe à Ibex pour fournir des solutions de diagnostic avancées basées sur l'IA

Technologie De La Santé Détection Du Cancer Pathologie Numérique Diagnostic Par IA Flux De Travail Cliniques
COMMUNIQUÉ DE PRESSE

publié le 28/08/2024 à 09:00, il y a 2 mois 24 jours

Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions
Tribun Health partners with Ibex Medical Analytics to offer AI-powered cancer diagnostics through CaloPix® IMS, enhancing healthcare outcomes worldwide

Tribun Health Healthcare Ibex Medical Analytics AI-powered Cancer Diagnostics CaloPix® IMS
BRÈVE

publiée le 23/04/2024 à 14:05, il y a 6 mois 27 jours

Tribun Health Secures Over €600,000 in Bpifrance I-Nov Wave 11 Competition for Pathomix Project

Tribun Health Digital Pathology Precision Medicine Bpifrance Funding France 2030 Plan
BRÈVE

publiée le 23/04/2024 à 14:05, il y a 6 mois 27 jours

Tribun Health obtient plus de 600 000 € dans le cadre du concours Bpifrance I-Nov Wave 11 pour le projet Pathomix

Médecine De Précision Santé Du Tribun Financement Bpifrance Pathologie Numérique Plan France 2030
COMMUNIQUÉ DE PRESSE

publié le 23/04/2024 à 14:00, il y a 6 mois 27 jours

Tribun Health, Winner of the I-Nov Competition of Bpifrance, Obtains Funding of Over €600,000 for Its Pathomix Project
Tribun Health wins i-Nov Wave 11 competition with innovative image management software CaloPix® for digital pathology, focusing on data interoperability and healthcare research advancements

Tribun Health Digital Pathology CaloPix Healthcare Research I-Nov Wave 11 Competition
COMMUNIQUÉ DE PRESSE

publié le 07/02/2024 à 14:00, il y a 9 mois 13 jours

Tribun Health Clinches Best in KLAS Award for the Third Consecutive Year
Tribun Health wins Best in KLAS award for Digital Pathology (Europe) for the third consecutive year. Recognition underscores commitment to excellence and innovation in computational pathology

Innovation Healthcare Technology Tribun Health Digital Pathology Best In KLAS Award
COMMUNIQUÉ DE PRESSE

publié le 11/01/2024 à 07:30, il y a 10 mois 10 jours

CGI and Tribun Health Selected to Lead Digital Pathology Transformation in Region Sjælland
CGI (TSX:GIB.A) and Tribun Health have announced their partnership with Region Sjælland in Denmark to implement digital pathology solutions, CaloPix®, with the aim of modernizing pathology services and enhancing efficiency, accuracy, and innovation in diagnostics. The strategic collaboration leverages CGI's expertise in IT infrastructure and solutions, along with Tribun Health's award-winning solution, to support Region Sjælland's vision of becoming a digital pathology leader in Scandinavia.

CGI Tribun Health Digital Pathology CaloPix Region Sjælland
COMMUNIQUÉ DE PRESSE

publié le 04/12/2023 à 13:50, il y a 11 mois 17 jours

Spire Healthcare Advances Pathology Services With Tribun Health Partnership
Spire Healthcare partners with Tribun Health to enhance pathology services and launch new digital infrastructure, achieving operational resilience and high-quality care

Tribun Health Spire Healthcare Pathology Services Digital Infrastructure Healthcare Innovation
COMMUNIQUÉ DE PRESSE

publié le 11/09/2023 à 14:00, il y a 1 année 2 mois

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 52 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 52 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 52 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 42 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 30 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:30, il y a 20 minutes

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 20 minutes

Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 50 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 50 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 50 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:41, il y a 9 minutes

Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Publié le 21/11/2024 à 13:15, il y a 35 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 1 heure 15 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 35 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 43 minutes

IVU AG publishes Quarterly Report Q3-2024